Vox Markets Interview with Avacta CEO Alastair Smith

0 المشاهدات· 09/19/23
The Vox Markets Podcast
The Vox Markets Podcast
0 مشتركين
0
في

Following today’s “stunning” safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.

أظهر المزيد

 0 تعليقات sort   ترتيب حسب


التالي